Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;31(3):993-1005.
doi: 10.1111/odi.15145. Epub 2024 Oct 6.

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021)

Affiliations

Oropharyngeal Adverse Events to Drugs and Vaccines: Pharmacovigilance Data From Italy (2019-2021)

Liberata Sportiello et al. Oral Dis. 2025 Mar.

Abstract

Objectives: The aim of this study was to perform a descriptive analysis of oropharyngeal adverse events (AEs) related to drugs and/or vaccines in order to provide useful information for clinicians.

Methods: Data related to three regions of Italy were analyzed from 2019 to 2021 by using the National Pharmacovigilance database.

Results: Among overall 67,384 cases, 2773 (4.1%) reported at least one oropharyngeal AE. Most cases referred to females (71.0%) and adults (70.8%). The majority of cases were reported as not serious (68.4%) and the outcome was mainly positive (73.5%). The cases related to drugs (52.2%) were slightly more than those related to vaccines (47.8%), the latter nearly completely represented by COVID-19 vaccines. Among 3324 oropharyngeal AEs, the most commonly reported were oropharyngeal conditions (65.9%). The most reported AEs related to vaccines were paresthesia oral and oropharyngeal pain, whereas the most reported AEs related to drugs were throat tightness and angioedema. A marked under-reporting of osteonecrosis of the jaw (2.9%) was observed, despite this risk was well documented in the same country.

Conclusions: This analysis suggested an under-reporting of oropharyngeal AEs and the need to better train dentists, dental hygienists, and also general practitioners.

Keywords: database; dentists; oropharyngeal adverse events; pharmacovigilance; spontaneous reporting.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
(a) Trend of the total number of Individual Case Safety Reports (ICSRs) and ICSRs with O‐AEs or without O‐AEs from 2019 to 2021. (b) Frequency of ICSRs containing at least one O‐AE stratified by drug and vaccine from 2019 to 2021. ICSR, Individual Case Safety Report; O‐AE, oral adverse event.
FIGURE 2
FIGURE 2
“Top twenty” preferred term (PTs) reported in the Individual Case Safety Reports (ICSRs) containing at least one oropharyngeal adverse event (o‐AEs) from 2009 to 2021.

References

    1. Ahsanuddin, S. , Jin R., Dhanda A. K., et al. 2023. “Otolaryngologic Side Effects After COVID‐19 Vaccination.” Laryngoscope 134, no. 3: 1163–1168. 10.1002/lary.30923. - DOI - PubMed
    1. Aronson, J. K. 2003. “Joining the DoTS: New Approach to Classifying Adverse Drug Reactions.” BMJ 327, no. 7425: 1222–1225. 10.1136/bmj.327.7425.1222. - DOI - PMC - PubMed
    1. Aswath, N. , and Rakshana R.. 2022. “Drug Induced Erythema Multiforme of the Oral Cavity.” Archive of Clinical Cases 9, no. 4: 157–160. 10.22551/2022.37.0904.10224. - DOI - PMC - PubMed
    1. Bakhtiari, S. , Sehatpour M., Mortazavi H., and Bakhshi M.. 2018. “Orofacial Manifestation of Adverse Drug Reactions: A Review Study.” Medicine and Pharmacy Reports 91, no. 1: 27–36. 10.15386/cjmed-748. - DOI - PMC - PubMed
    1. Bedogni, A. , Fedele S., Bedogni G., et al. 2014. “Staging of Osteonecrosis of the Jaw Requires Computed Tomography for Accurate Definition of the Extent of Bony Disease.” British Journal of Oral and Maxillofacial Surgery 52, no. 7: 603–608. 10.1016/j.bjoms.2014.04.009. - DOI - PubMed